*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ A/DT new/JJ study/NN ]
found/VBD that/IN 
[ a/DT ]
commonly/RB used/VBN 
[ drug/NN ]
for/IN treating/VBG 
[ high/JJ blood/NN pressure/NN ]
increases/VBZ 
[ some/DT risk/NN factors/NNS ]
associated/VBN with/IN 
[ heart/NN attacks/NNS ]
and/CC 
[ diabetes/NN ]
./. 

======================================

[ The/DT surprising/JJ finding/NN ]
from/IN 
[ a/DT group/NN ]
of/IN 
[ Swedish/JJ researchers/NNS ]
said/VBD that/IN 
[ a/DT diuretic/JJ drug/NN ]
called/VBD 
[ hydrochlorothiazide/NN ]
reduced/VBD 
[ the/DT body/NN 's/POS ability/NN ]
to/TO handle/VB 
[ blood/NN sugars/NNS ]
,/, 
[ a/DT cause/NN ]
of/IN 
[ diabetes/NN ]
,/, and/CC also/RB increased/VBD 
[ blood/NN levels/NNS ]
of/IN 
[ cholesterol/NN ]
and/CC 
[ triglycerides/NNS ]
,/, 
[ fats/NNS ]
associated/VBN with/IN 
[ coronary/JJ artery/NN disease/NN ]
./. 

======================================

[ Hydrochlorothiazides/NNS ]
are/VBP sold/VBN by/IN 
[ numerous/JJ drug/NN makers/NNS ]
world-wide/RB ./. 

[ The/DT top-selling/JJ product/NN ]
containing/VBG 
[ the/DT drug/NN ]
in/IN 
[ the/DT U.S./NNP ]
is/VBZ 
[ SmithKline/NNP Beecham/NNP PLC/NNP 's/POS Dyazide/NNP ]
./. 

======================================

[ The/DT study/NN ]
,/, published/VBN in/IN 
[ today/NN 's/POS New/NNP England/NNP Journal/NNP ]
of/IN 
[ Medicine/NNP ]
,/, said/VBD 
[ a/DT different/JJ blood/NN pressure/NN drug/NN ]
,/, 
[ Capoten/NNP ]
,/, does/VBZ n't/RB cause/VB 
[ the/DT same/JJ problems/NNS ]
./. 

[ The/DT finding/NN ]
is/VBZ certain/JJ to/TO stir/VB up/RP 
[ aggressive/JJ marketing/NN battles/NNS ]
between/IN 
[ Capoten/NNP 's/POS maker/NN ]
,/, 
[ Squibb/NNP Corp./NNP ]
,/, and/CC 
[ makers/NNS ]
of/IN 
[ diuretics/NNS ]
./. 

======================================

[ Capoten/NNP ]
and/CC 
[ a/DT similar/JJ drug/NN ]
,/, 
[ Vasotec/NNP ]
,/, sold/VBN by/IN 
[ Merck/NNP ]
&/CC 
[ Co./NNP ]
,/, have/VBP been/VBN gaining/VBG 
[ wide/JJ use/NN ]
in/IN 
[ recent/JJ years/NNS ]
,/, often/RB as/IN 
[ substitutes/NNS ]
for/IN 
[ diuretics/NNS ]
in/IN treating/VBG 
[ mild/JJ ]
to/TO 
[ moderate/JJ hypertension/NN ]
./. 

[ World-wide/JJ sales/NNS ]
of/IN 
[ Capoten/NNP ]
and/CC 
[ Vasotec/NNP ]
,/, 
[ which/WDT ]
are/VBP much/RB more/RBR expensive/JJ than/IN 
[ diuretics/NNS ]
,/, are/VBP expected/VBN to/TO be/VB about/RB 
[ $/$ 2/CD billion/CD this/DT year/NN ]
./. 

======================================

Specifically/RB ,/, 
[ the/DT new/JJ study/NN ]
found/VBD that/IN 
[ patients/NNS ]
receiving/VBG 
[ the/DT diuretic/NN ]
had/VBD 
[ an/DT 11/CD %/NN decrease/NN ]
in/IN 
[ a/DT test/NN ]

[ that/WDT ]
measured/VBD 
[ the/DT body/NN 's/POS handling/NN ]
of/IN 
[ glucose/NN ]
,/, 
[ a/DT blood/NN sugar/NN ]
,/, while/IN 
[ those/DT ]
given/VBN 
[ Capoten/NNP ]
increased/VBD 
[ handling/NN ]
of/IN 
[ glucose/NN ]
by/IN 
[ 11/CD %/NN ]
./. 

[ The/DT diuretic/NN ]
increased/VBD 
[ triglycerides/NNS ]
by/IN 
[ 15/CD %/NN ]
and/CC 
[ cholesterol/NN ]
by/IN 
[ 6/CD %/NN ]
./. 

[ Capoten/NNP ]
had/VBD 
[ no/DT effect/NN ]
on/IN 
[ the/DT body/NN fats/NNS ]
./. 

======================================

[ Several/JJ researchers/NNS ]
previously/RB had/VBD suggested/VBN that/IN 
[ people/NNS ]
with/IN 
[ high/JJ blood/NN pressure/NN ]
are/VBP especially/RB vulnerable/JJ to/TO 
[ diabetes/NN ]
,/, and/CC 
[ other/JJ studies/NNS ]
have/VBP found/VBN that/IN 
[ some/DT diuretic/JJ drugs/NNS ]
can/MD modestly/RB increase/VB 
[ blood/NN levels/NNS ]
of/IN 
[ certain/JJ fats/NNS ]
./. 

But/CC 
[ the/DT new/JJ report/NN ]
,/, by/IN 
[ doctors/NNS ]
at/IN 
[ Uppsala/NNP University/NNP ]
,/, 
[ Uppsala/NNP ]
,/, 
[ Sweden/NNP ]
,/, is/VBZ 
[ the/DT most/RBS detailed/JJ comparison/NN ]
of/IN 
[ two/CD ]
of/IN 
[ the/DT ]
more/RBR commonly/RB used/VBN 
[ therapies/NNS ]
for/IN 
[ high/JJ blood/NN pressure/NN ]
./. 

======================================

[ The/DT researchers/NNS ]
cautioned/VBD ,/, however/RB ,/, that/IN 
[ their/PRP$ study/NN ]
provided/VBD 
[ no/DT specific/JJ evidence/NN ]

[ that/DT use/NN ]
of/IN 
[ either/DT type/NN ]
of/IN 
[ drug/NN ]
increased/VBD or/CC decreased/VBD 
[ the/DT incidence/NN ]
of/IN 
[ diabetes/NN ]
or/CC 
[ heart/NN attacks/NNS ]
./. 

``/`` 
[ It/PRP ]
is/VBZ possible/JJ ,/, but/CC not/RB proved/VBN in/IN 
[ this/DT study/NN ]
,/, that/IN 
[ these/DT changes/NNS ]
may/MD contribute/VB to/TO 
[ the/DT risk/NN ]
for/IN 
[ diabetes/NN ]
and/CC 
[ coronary/JJ heart/NN disease/NN ]
,/, ''/'' 
[ the/DT researchers/NNS ]
wrote/VBD in/IN 
[ their/PRP$ report/NN ]
./. 

======================================

In/IN 
[ Philadelphia/NNP ]
,/, 
[ SmithKline/NNP ]
said/VBD 
[ that/IN its/PRP$ Dyazide/NNP product/NN ]
also/RB contains/VBZ 
[ potassium/NN ]
,/, 
[ which/WDT ]
may/MD counter/VB 
[ effects/NNS ]
seen/VBN in/IN 
[ the/DT study/NN ]
./. 

[ The/DT company/NN ]
also/RB said/VBD that/IN while/IN 
[ some/DT research/NN ]
has/VBZ uncovered/VBN 
[ short-term/JJ changes/NNS ]
like/IN 
[ those/DT ]
reported/VBN by/IN 
[ the/DT Swedish/JJ researchers/NNS ]
,/, affects/NNS on/IN 
[ cholesterol/NN ]
were/VBD n't/RB upheld/VBN in/IN 
[ longer/JJR studies/NNS ]
./. 

[ The/DT Swedish/JJ report/NN ]
looked/VBD at/IN 
[ changes/NNS ]
over/IN 
[ two/CD separate/JJ four-month/JJ periods/NNS ]
./. 

======================================

[ Squibb/NNP ]
,/, however/RB ,/, is/VBZ already/RB making/VBG 
[ use/NN ]
of/IN 
[ the/DT report/NN ]
./. 

[ Last/JJ weekend/NN ]
,/, 
[ the/DT Princeton/NNP ]
,/, 
[ N.J./NNP ]
,/, 
[ company/NN ]
brought/VBD 
[ the/DT report/NN 's/POS authors/NNS ]
,/, 
[ Thomas/NNP Pollare/NNP ]
and/CC 
[ Hans/NNP Lithell/NNP ]
,/, to/TO 
[ New/NNP York/NNP ]
to/TO meet/VB with/IN 
[ 25/CD top/JJ U.S./NNP cardiologists/NNS ]
./. 

[ They/PRP ]
will/MD also/RB be/VB featured/VBN at/IN 
[ a/DT press/NN conference/NN ]
in/IN 
[ New/NNP York/NNP today/NN ]
,/, 
[ which/WDT ]
will/MD be/VB 
[ videotaped/VBN ]
./. 

[ The/DT tape/NN ]
and/CC 
[ the/DT study/NN ]
will/MD be/VB made/VBN available/JJ to/TO 
[ doctors/NNS ]
./. 

[ Squibb/NNP 's/POS Swedish/JJ unit/NN ]
provided/VBD about/RB 
[ $/$ 90,000/CD ]
,/, or/CC 
[ 10/CD %/NN ]
,/, of/IN 
[ the/DT study/NN 's/POS ]
funding/NN ./. 

======================================

[ Squibb/NNP shares/NNS ]
jumped/VBD 
[ $/$ 2.50/CD ]
to/TO 
[ $/$ 122.25/CD ]
and/CC 
[ SmithKline/NNP shares/NNS ]
fell/VBD 
[ 87.5/CD cents/NNS ]
to/TO close/VB at/IN 
[ $/$ 45.125/CD ]
in/IN 
[ New/NNP York/NNP Stock/NNP Exchange/NNP composite/JJ trading/NN yesterday/NN ]
./. 

[ Details/NNS ]
of/IN 
[ studies/NNS ]
in/IN 
[ the/DT New/NNP England/NNP Journal/NNP ]
sometimes/RB reach/VBP 
[ investors/NNS ]
prior/RB to/TO 
[ publication/NN ]
./. 

======================================

Meanwhile/RB ,/, 
[ the/DT Swedish/JJ researchers/NNS ]
said/VBD 
[ they/PRP ]
have/VBP received/VBN funding/NN ,/, by/IN 
[ some/DT other/JJ drug/NN makers/NNS ]
,/, to/TO conduct/VB 
[ similar/JJ studies/NNS ]
comparing/VBG 
[ the/DT effects/NNS ]
of/IN 
[ other/JJ competitive/JJ anti-hypertensive/JJ drugs/NNS ]
on/IN 
[ the/DT same/JJ risk/NN factors/NNS ]
./. 
